Diammonium glycyrrhizinate enteric capsule is not recommended in pregnancy. The use of the drug in pregnant women needs to be done under the advice of a doctor. Diammonium glycyrrhizinate enteric capsule is mainly used for the treatment of acute and chronic hepatitis accompanied by elevated ghrelin aminotransferase, in the process of use may cause nausea and vomiting, abdominal distension or skin allergies and other adverse reactions. The use of Diammonium glycyrrhizinate enteric-coated capsules is usually contraindicated in people who are allergic to the components of the drug or have severe hypokalemia or hypernatremia. The drug is not recommended for use in pregnant women because of the uncertainty of the damage to the fetus and the pregnant woman. If a woman needs treatment for acute or chronic hepatitis during pregnancy, she should, under the guidance of a doctor, choose a drug that does not cause significant irritation to the fetus or herself. For mild liver damage or localized inflammation, dietary modifications and lifestyle improvements can be made to relieve the discomfort, and drug treatment can be considered after delivery. Pregnant women should choose carefully under the guidance of a doctor when using diammonium glycyrrhizinate enteric-coated capsules or other drugs.